Company intelligence / Profile preview
Mayado Pharmaceutical
Kobe, Hyogo, Japanmayado.jp ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
Mayado Pharmaceutical is a Japanese pharmaceutical company that specializes in the manufacture and sale of over-the-counter (OTC) drugs and traditional Kampo medicines. Founded in 1947 and headquartered in Kobe, the company offers a diverse portfolio of products targeting metabolic diseases, gastrointestinal health, and respiratory symptoms. In 2012, Mayado became a subsidiary of Rohto Pharmaceutical, leveraging its parent company's distribution network to expand its reach. The company is well-regarded for its focus on blending traditional herbal wisdom with modern pharmaceutical standards to provide accessible healthcare solutions.
- Therapeutic areas
- EndocrinologyCardiovascularDermatologyInfectious DiseasesGastroenterology
- Modalities
- Small molecule
- Industry
- Biotech
02
Drug pipeline
1 assetBeyond the preview
Go deeper on Mayado Pharmaceutical.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Mayado Pharmaceutical.